Wave Life Sciences Ltd

(NASDAQ:WVE)

Latest On Wave Life Sciences Ltd (WVE):

Date/Time Type Description Signal Details
2023-05-23 19:33 ESTNewsWave Life Sciences crashes on decision to drop neurology asset on trial setbackN/A
2023-05-03 17:10 ESTNewsWave Life Sciences GAAP EPS of -$0.27 misses by $0.23, revenue of $12.93M misses by $25.67MN/A
2023-05-03 17:10 ESTNewsWave Life Sciences Ltd. (WVE) Q1 2023 Earnings Call TranscriptN/A
2023-05-02 16:03 ESTNewsWave Life Sciences Q1 2023 Earnings PreviewN/A
2023-03-22 19:19 ESTNewsWave Life Sciences GAAP EPS of -$0.47 misses by $0.06, revenue of $1.24M misses by $1.16MN/A
2023-03-22 19:18 ESTNewsWave Life Sciences Ltd. 2022 Q4 - Results - Earnings Call PresentationN/A
2023-03-22 19:18 ESTNewsWave Life Sciences Ltd (WVE) Q4 2022 Earnings Call TranscriptN/A
2023-03-21 11:59 ESTNewsWave Life Sciences Q4 2022 Earnings PreviewN/A
2023-03-13 05:38 ESTNewsRAPT Therapeutics, Repare Therapeutics among biotechs to disclose exposure to Silicon Valley BankN/A
2023-01-08 08:22 ESTNewsWave Life Sciences: Huntington's Hypotheses, GSK Collaboration Catalysts To Move The NeedleN/A
2022-12-13 14:27 ESTNewsWave Life stock surges 20% in team up with GSK for genetic diseasesN/A
2022-11-11 01:23 ESTNewsWave Life Sciences Ltd. 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-11 01:23 ESTNewsWave Life Sciences Ltd. (WVE) Q3 2022 Earnings Call TranscriptN/A
2022-11-10 07:50 ESTNewsWave Life Sciences GAAP EPS of -$0.42 beats by $0.08, revenue of $0.29M misses by $5.11MN/A
2022-11-09 14:49 ESTNewsWave Life Sciences Q3 2022 Earnings PreviewN/A
2022-09-21 00:13 ESTNewsWave Life's WVE-003 shows promise in interim data of Huntington's disease trialN/A
2022-08-11 17:59 ESTNewsWave Life Sciences GAAP EPS of -$0.62 misses by $0.08, revenue of $0.37MN/A
2022-08-11 17:59 ESTNewsWave Life Sciences Ltd. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-11 17:59 ESTNewsWave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-11 01:42 ESTNewsWave Life Sciences Q2 2022 Earnings PreviewN/A
2022-06-22 10:01 ESTNewsRa Capital Management raises passive stake in Wave Life SciencesN/A
2022-06-15 00:46 ESTNewsWave Life Sciences to raise $70M in stock offeringN/A
2022-05-14 05:36 ESTNewsWave Life Sciences Ltd.'s (WVE) CEO Paul Bolno on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-14 05:36 ESTNewsWave Life Sciences slips as H.C. Wainwright lowers targetN/A
2022-05-13 02:49 ESTNewsWave Life Sciences GAAP EPS of -$0.62 misses by $0.06, revenue of $1.75M misses by $2.11MN/A
2022-05-13 02:49 ESTNewsWave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-13 02:49 ESTNewsWave Life Sciences Ltd. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-12 06:46 ESTNewsWave Life Sciences Q1 2022 Earnings PreviewN/A
2022-04-05 01:08 ESTNewsWave Life gains most in more than a year after early-stage data for ALS drugN/A
2022-03-31 02:14 ESTNewsWave Life Sciences (WVE) Investor Presentation - SlideshowN/A
2022-03-05 07:12 ESTNewsWave Life Sciences Ltd. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-03-03 20:07 ESTNewsWave Life Sciences GAAP EPS of -$0.61 misses by $0.06, revenue of $1.76M misses by $11.98MN/A
2022-03-03 20:06 ESTNewsWave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-03 02:56 ESTNewsWave Life Sciences Q4 2021 Earnings PreviewN/A
2022-01-25 21:00 ESTNewsWave Life Sciences' FTD, ALS clinical program to get investment from 2 organizationsN/A
2021-11-10 18:38 ESTNewsWave Life Sciences EPS beats by $0.52, beats on revenueN/A
2021-11-10 18:37 ESTNewsWave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-10 18:37 ESTNewsWave Life Sciences Ltd. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-09 19:57 ESTNewsWave Life Sciences Q3 2021 Earnings PreviewN/A
2021-10-18 23:49 ESTNewsWave Life Sciences, Takeda amend CNS research collaborationN/A
2021-10-18 23:49 ESTNewsTakeda discontinues research with Wave for certain CNS programs; Wave to get $22.5MN/A
2021-09-30 02:27 ESTNewsDosing underway in Wave Life's mid-stage WVE-N531 study in Duchenne muscular dystrophyN/A
2021-09-29 03:19 ESTNewsWave Life Sciences falls after presentation on its RNA editing capability (Updated)N/A
2021-09-09 14:39 ESTNewsWave Life Sciences gets dosing underway in early-stage Huntington’s disease trialN/A
2021-08-17 03:33 ESTNewsWave Life Sciences Ltd. 2021 Q2 - Results - Earnings Call PresentationN/A
2021-08-08 22:24 ESTNewsWave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-05 16:13 ESTNewsWave Life Sciences EPS misses by $0.14, misses on revenueN/A
2021-07-22 09:27 ESTNewsWave Life Sciences posts proof-of-concept data from genetic disorder studyN/A
2021-07-22 08:54 ESTNewsDosing underway in Wave Life Sciences' mid-stage WVE-004 study in neurodegenerative diseasesN/A
2021-03-29 20:19 ESTNewsWave Life Sciences falls on setback for Huntington’s disease trial (updated)N/A

About Wave Life Sciences Ltd (WVE):

Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces of novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company is primarily developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. It develops WVE-120101 and WVE-120102, a stereopure therapeutic candidates, which are in Phase 1b/2a clinical trials for the treatment of Huntington's disease (HD); WVE-003, mutant huntingtin SNP3 program for the treatment of HD; WVE-004, C9orf72 program for the treatment of amyotrophic lateral sclerosis and frontotemporal dementia; WVE-N531, our Exon 53 program for the treatment of Duchenne muscular dystrophy; and ATXN3 program in SCA3. The company has collaboration agreements with Pfizer Inc., Takeda Pharmaceutical Company Limited, University of Oxford, and University of Massachusetts. Wave Life Sciences Ltd. was incorporated in 2012 and is based in Singapore.

See Advanced Chart

General

  • Name Wave Life Sciences Ltd
  • Symbol WVE
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 217
  • Fiscal Year EndDecember
  • IPO Date2015-11-11
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.wavelifesciences.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 17.92
  • Price/Book (Most Recent Quarter) 5.85
  • Enterprise Value Revenue 16.38
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.80
  • Next Year EPS Estimate -$2.16
  • Next Quarter EPS Estimate -$0.53
  • Operating Margin -764%
  • Return on Assets -34%
  • Return on Equity -185%
  • Revenue 20.08 million
  • Earnings Per Share -$5.15
  • Revenue Per Share $0.51
  • Gross Profit -110867000
  • Quarterly Earnings Growth 293.3%
View More

Highlights

  • Market Capitalization 486.05 million
  • EBITDA -173971008
  • PE Ratio -9.74
  • Analyst Target Price $16.86
  • Book Value Per Share $1.70
View More

Share Statistics

  • Shares Outstanding 49 million
  • Shares Float 31.16 million
  • % Held by Insiders 1297%
  • % Held by Institutions 76.71%
  • Shares Short 4.92 million
  • Shares Short Prior Month 4.38 million
  • Short Ratio 9.71
  • Short % of Float 13%
  • Short % of Shares Outstanding 10%
View More

Technicals

  • Beta 0.37
  • 52 Week High $19.98
  • 52 Week Low $6.76
  • 50 Day Moving Average 10.18
  • 200 Day Moving Average 9.71
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Wave Life Sciences Ltd (WVE) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Wave Life Sciences Ltd (WVE) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-04$9.44 million-$0.59-$0.602.14%
2020-09-302020-11-09$N/A-$0.86-$0.73-17.81%
2020-06-302020-08-10$N/A-$1.15-$1.07-7.48%
2020-03-312020-05-11$4.16 million-$1.38-$1.32-4.41%
2019-12-312020-03-02$2.4 million-$1.65-$1.46-13.35%
2019-09-302019-11-05$2.93 million-$1.48-$1.37-8.37%
2019-06-302019-07-29$7.63 million-$1.22-$1.00-22.31%
2019-03-312019-05-10$3.03 million-$1.36-$1.20-13.1%
2018-12-312019-03-01$3.62 million-$1.28-$1.25-2.81%
2018-09-302018-11-09$4.49 million-$1.28-$1.24-2.89%
2018-06-302018-08-09$4.88 million-$1.23-$1.10-11.56%
2018-03-312018-05-09$1.42 million-$1.26-$0.91-38.97%
2017-12-312018-03-12$1.68 million-$1.10-$1.04-5.43%
2017-09-302017-11-09$1.32 million-$0.94-$0.984.08%
2017-06-302017-08-09$1.1 million-$0.92-$0.81-13.23%
2017-03-312017-05-10$383000-$0.89-$0.76-17.49%
2016-12-312017-03-16$676000-$0.81-$0.67-20.45%
2016-09-302016-11-09$392000-$0.75-$0.53-41.51%
2016-06-302016-08-15$417000-$0.51-$0.37-37.84%
2016-03-312016-05-16$N/A-$0.36-$0.396.9%
2015-12-312016-03-30$N/A-$0.47-$0.32-46.88%
2015-09-302015-11-11$26000-$0.54-$0.29-86.21%

Wave Life Sciences Ltd (WVE) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Wave Life Sciences Ltd (WVE) Chart:

Wave Life Sciences Ltd (WVE) News:

Below you will find a list of latest news for Wave Life Sciences Ltd (WVE) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Wave Life Sciences Ltd (WVE) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-05-1530CALL0 0684.89TRUE00
2026-05-1540CALL0 50TRUE00
2026-05-1552.25CALL0 38235.87TRUE00
2026-05-1561.25CALL0 3790TRUE00
2026-05-1570.3CALL121 175989.23TRUE-0.1-0.25
2026-05-1580.05CALL55 1219102.34FALSE-0.05-0.5
2026-05-1590.06CALL0 215182.46FALSE00
2026-05-15100CALL0 72186.58FALSE00
2026-05-15110CALL0 6488.75FALSE00
2026-05-15120CALL0 6538.74FALSE00
2026-05-15130CALL0 203291.51FALSE00
2026-05-15140CALL0 342576.22FALSE00
2026-05-15150.03CALL1 272354.69FALSE0.030
2026-05-15160CALL0 0642.22FALSE00
2026-05-15170CALL0 2719.4FALSE00
2026-05-15180CALL0 01006.67FALSE00
2026-05-15190CALL0 0806.74FALSE00
2026-05-15200CALL0 11059.68FALSE00
2026-05-15210CALL0 0841.89FALSE00
2026-05-1530PUT0 0438.88FALSE00
2026-05-1540PUT0 0704.35FALSE00
2026-05-1550PUT0 105199.67FALSE00
2026-05-1560PUT0 10331109.17FALSE00
2026-05-1570.2PUT156 100679.84FALSE0.20
2026-05-1580.9PUT5 134201.15TRUE0.90
2026-05-1590PUT0 1530TRUE00
2026-05-15100PUT0 10TRUE00
2026-05-15110PUT0 00TRUE00
2026-05-15120PUT0 00TRUE00
2026-05-15130PUT0 0582.38TRUE00
2026-05-15140PUT0 0621.76TRUE00
2026-05-15150PUT0 00TRUE00
2026-05-15160PUT0 0689.75TRUE00
2026-05-15170PUT0 00TRUE00
2026-05-15180PUT0 00TRUE00
2026-05-15190PUT0 00TRUE00
2026-05-15200PUT0 00TRUE00
2026-05-15210PUT0 00TRUE00
2026-06-1810CALL0 0490.35TRUE00
2026-06-1820CALL0 0311.98TRUE00
2026-06-1830CALL0 0269.17TRUE00
2026-06-1840CALL0 0169.4TRUE00
2026-06-1850CALL0 10171TRUE00
2026-06-1860CALL0 13118.11TRUE00
2026-06-1871CALL17 580105.72TRUE10
2026-06-1880.55CALL207 1126296.74FALSE-0.2-0.27
2026-06-1890.45CALL1 137113.52FALSE0.450
2026-06-18100.28CALL0 395100.29FALSE00
2026-06-18110.35CALL0 18112.56FALSE00
2026-06-18120CALL0 0160.07FALSE00
2026-06-18130CALL0 0173.97FALSE00
2026-06-18140CALL0 0186.39FALSE00
2026-06-18150.13CALL1 0150.41FALSE0.130
2026-06-1810PUT0 1771.45FALSE00
2026-06-1820PUT0 0285.8FALSE00
2026-06-1830PUT0 0285.82FALSE00
2026-06-1840PUT0 0207.74FALSE00
2026-06-1850.15PUT0 1491.34FALSE00
2026-06-1860.35PUT3 11093.02FALSE-0.05-0.13
2026-06-1870.75PUT0 46199.52FALSE00
2026-06-1881.35PUT0 387118.73TRUE00
2026-06-1890PUT0 097.47TRUE00
2026-06-18100PUT0 2100.05TRUE00
2026-06-18110PUT0 296.26TRUE00
2026-06-18120PUT0 00TRUE00
2026-06-18130PUT0 00TRUE00
2026-06-18140PUT0 00TRUE00
2026-06-18150PUT0 00TRUE00
2026-07-1710CALL0 0368.01TRUE00
2026-07-1720CALL0 30233.18TRUE00
2026-07-1730CALL0 0201.28TRUE00
2026-07-1740CALL0 00TRUE00
2026-07-1752.6CALL0 125121.24TRUE00
2026-07-1762CALL20 209125.19TRUE20
2026-07-1771.15CALL0 914102.25TRUE00
2026-07-1780.8CALL25 182593.22FALSE00
2026-07-1790.55CALL20 34494.04FALSE00
2026-07-17100.45CALL0 40094.46FALSE00
2026-07-17110.2CALL0 870108.26FALSE00
2026-07-17120.23CALL0 7595.18FALSE00
2026-07-17130CALL0 188130.64FALSE00
2026-07-17140CALL0 327140.01FALSE00
2026-07-17150.2CALL0 705148.46FALSE00
2026-07-17160CALL0 97156.17FALSE00
2026-07-17170CALL0 20175.03FALSE00
2026-07-17180.05CALL0 161192.75FALSE00
2026-07-17190CALL0 90175.87FALSE00
2026-07-17200.06CALL49 157108.65FALSE0.060
2026-07-17210CALL0 20186.87FALSE00
2026-07-17220CALL0 1191.87FALSE00
2026-07-17230CALL0 4196.6FALSE00
2026-07-17240.05CALL0 19201.07FALSE00
2026-07-17250.07CALL0 344194.67FALSE00
2026-07-17260CALL0 238209.35FALSE00
2026-07-17270CALL0 1213.19FALSE00
2026-07-17280CALL0 17216.87FALSE00
2026-07-17290CALL0 2220.39FALSE00
2026-07-17300CALL0 13223.76FALSE00
2026-07-17310CALL0 11227FALSE00
2026-07-17320CALL0 191230.11FALSE00
2026-07-17330CALL0 9233.1FALSE00
2026-07-17340CALL0 1235.99FALSE00
2026-07-17350CALL0 127238.78FALSE00
2026-07-1710PUT0 0294.72FALSE00
2026-07-1720PUT0 11215.67FALSE00
2026-07-1730PUT0 0160.02FALSE00
2026-07-1740PUT0 5156.98FALSE00
2026-07-1750PUT0 171111.76FALSE00
2026-07-1760.5PUT0 35183.66FALSE00
2026-07-1770PUT0 28473.64FALSE00
2026-07-1780PUT0 27488.42TRUE00
2026-07-1790PUT0 22100.29TRUE00
2026-07-17100PUT0 11183.37TRUE00
2026-07-17114PUT0 13763.91TRUE00
2026-07-17120PUT0 1410TRUE00
2026-07-17130PUT0 5482.55TRUE00
2026-07-17140PUT0 150TRUE00
2026-07-17150PUT0 1350TRUE00
2026-07-17160PUT0 30TRUE00
2026-07-17170PUT0 00TRUE00
2026-07-17180PUT0 0151.66TRUE00
2026-07-17190PUT0 0197.12TRUE00
2026-07-17200PUT0 00TRUE00
2026-07-17210PUT0 00TRUE00
2026-07-17220PUT0 0202.98TRUE00
2026-07-17230PUT0 0208.18TRUE00
2026-07-17240PUT0 00TRUE00
2026-07-17250PUT0 0246.46TRUE00
2026-07-17260PUT0 00TRUE00
2026-07-17270PUT0 0226.65TRUE00
2026-07-17280PUT0 0230.78TRUE00
2026-07-17290PUT0 00TRUE00
2026-07-17300PUT0 00TRUE00
2026-07-17310PUT0 00TRUE00
2026-07-17320PUT0 00TRUE00
2026-07-17330PUT0 00TRUE00
2026-07-17340PUT0 00TRUE00
2026-07-17350PUT0 00TRUE00
2026-10-1630CALL0 5209.24TRUE00
2026-10-1640CALL0 0102.59TRUE00
2026-10-1650CALL0 196.98TRUE00
2026-10-1662.25CALL0 30103.89TRUE00
2026-10-1672.08CALL1 24110.96TRUE2.080
2026-10-1681.4CALL0 4683.74FALSE00
2026-10-1690.8CALL5 074.27FALSE0.80
2026-10-16100.75CALL5 2683.22FALSE0.750
2026-10-16110.75CALL0 085.63FALSE00
2026-10-16120.55CALL0 7285.97FALSE00
2026-10-16130CALL0 5391.38FALSE00
2026-10-16140.45CALL0 492.29FALSE00
2026-10-16150CALL0 1395.95FALSE00
2026-10-16160CALL0 0100.99FALSE00
2026-10-16170CALL0 5105.61FALSE00
2026-10-16180CALL0 3109.89FALSE00
2026-10-16190CALL0 2113.86FALSE00
2026-10-16200CALL0 6117.56FALSE00
2026-10-16210CALL0 1121.04FALSE00
2026-10-16250CALL0 65133.07FALSE00
2026-10-1630PUT0 0141.65FALSE00
2026-10-1640PUT0 0153.83FALSE00
2026-10-1650PUT0 12284.48FALSE00
2026-10-1660.87PUT2 1981.56FALSE0.870
2026-10-1671.3PUT0 11380.28FALSE00
2026-10-1680PUT0 678.65TRUE00
2026-10-1690PUT0 379.14TRUE00
2026-10-16100PUT0 1180.08TRUE00
2026-10-16110PUT0 281TRUE00
2026-10-16120PUT0 3379.23TRUE00
2026-10-16130PUT0 260.37TRUE00
2026-10-16140PUT0 00TRUE00
2026-10-16150PUT0 00TRUE00
2026-10-16160PUT0 076.53TRUE00
2026-10-16170PUT0 081.18TRUE00
2026-10-16180PUT0 0115.03TRUE00
2026-10-16190PUT0 00TRUE00
2026-10-16200PUT0 0102.7TRUE00
2026-10-16210PUT0 0135.97TRUE00
2026-10-16250PUT0 00TRUE00
2026-12-1830CALL0 3572.35TRUE00
2026-12-1840CALL0 0120.24TRUE00
2026-12-1850CALL0 160113.97TRUE00
2026-12-1860CALL0 2104.83TRUE00
2026-12-1872CALL0 52147.07TRUE00
2026-12-1880CALL0 3289.63FALSE00
2026-12-1891.34CALL0 591.92FALSE00
2026-12-18101.05CALL0 48881.56FALSE00
2026-12-18110CALL0 388.91FALSE00
2026-12-18120.95CALL0 17286.51FALSE00
2026-12-18130CALL0 090.27FALSE00
2026-12-18140CALL0 491.9FALSE00
2026-12-18150.47CALL2 74986.63FALSE0.470
2026-12-18160CALL0 098.63FALSE00
2026-12-18170CALL0 8796.87FALSE00
2026-12-18180CALL0 54195.13FALSE00
2026-12-18200CALL0 216100.75FALSE00
2026-12-18220CALL0 61113.18FALSE00
2026-12-18250CALL0 133122.43FALSE00
2026-12-18270CALL0 1118.35FALSE00
2026-12-18300CALL0 95153.65FALSE00
2026-12-18320CALL0 2127.75FALSE00
2026-12-18350CALL0 218154.02FALSE00
2026-12-1830PUT0 0117.37FALSE00
2026-12-1840PUT0 088.01FALSE00
2026-12-1850PUT0 5387.52FALSE00
2026-12-1860PUT0 278.3FALSE00
2026-12-1870PUT0 11484.64FALSE00
2026-12-1880PUT0 165.45TRUE00
2026-12-1890PUT0 068.39TRUE00
2026-12-18100PUT0 6542.41TRUE00
2026-12-18110PUT0 245.43TRUE00
2026-12-18120PUT0 1478.07TRUE00
2026-12-18130PUT0 290.24TRUE00
2026-12-18140PUT0 090.76TRUE00
2026-12-18150PUT0 5790.21TRUE00
2026-12-18160PUT0 188.42TRUE00
2026-12-18170PUT0 00TRUE00
2026-12-18180PUT0 376.62TRUE00
2026-12-18200PUT0 100TRUE00
2026-12-18220PUT0 20TRUE00
2026-12-18250PUT0 40TRUE00
2026-12-18270PUT0 10TRUE00
2026-12-18300PUT0 00TRUE00
2026-12-18320PUT0 00TRUE00
2026-12-18350PUT0 00TRUE00
2027-01-1534.8CALL0 2685.35TRUE00
2027-01-1540CALL0 096.67TRUE00
2027-01-1550CALL0 258124.14TRUE00
2027-01-1562.76CALL0 193.13TRUE00
2027-01-1570CALL0 0142.14TRUE00
2027-01-1581.75CALL0 24110.95FALSE00
2027-01-1590CALL0 083.1FALSE00
2027-01-15101.1CALL0 147194.95FALSE00
2027-01-15110CALL0 085.74FALSE00
2027-01-15120.95CALL0 2981.28FALSE00
2027-01-15150CALL0 291.08FALSE00
2027-01-15170CALL0 386.67FALSE00
2027-01-15200.4CALL225 26094.75FALSE0.40
2027-01-15220CALL0 398.49FALSE00
2027-01-1530PUT0 0110.84FALSE00
2027-01-1540PUT0 683.18FALSE00
2027-01-1550.65PUT0 1089.05FALSE00
2027-01-1560PUT0 081.87FALSE00
2027-01-1570PUT0 6075.59FALSE00
2027-01-1580PUT0 7077.32TRUE00
2027-01-1590PUT0 075.9TRUE00
2027-01-15100PUT0 075.19TRUE00
2027-01-15110PUT0 079.22TRUE00
2027-01-15120PUT0 076.97TRUE00
2027-01-15150PUT0 079.87TRUE00
2027-01-15170PUT0 069.97TRUE00
2027-01-15200PUT0 00TRUE00
2027-01-15220PUT0 00TRUE00
2027-06-1730CALL0 9096.51TRUE00
2027-06-1753.6CALL0 279129.62TRUE00
2027-06-1782.3CALL0 6584.28FALSE00
2027-06-17100CALL0 0110.61FALSE00
2027-06-17120CALL0 20122.41FALSE00
2027-06-17150CALL0 1084.1FALSE00
2027-06-17170CALL0 0142.4FALSE00
2027-06-17200CALL0 0150.88FALSE00
2027-06-17220CALL0 0155.66FALSE00
2027-06-1730PUT0 0319.74FALSE00
2027-06-1750PUT0 1158.86FALSE00
2027-06-1780PUT0 950.08TRUE00
2027-06-17100PUT0 072.29TRUE00
2027-06-17120PUT0 077.03TRUE00
2027-06-17150PUT0 082.63TRUE00
2027-06-17170PUT0 079.84TRUE00
2027-06-17200PUT0 074.68TRUE00
2027-06-17220PUT0 080.12TRUE00
2028-01-2135.2CALL0 239118.29TRUE00
2028-01-2154CALL0 14598.42TRUE00
2028-01-2183CALL0 117105.93FALSE00
2028-01-21102.5CALL10 2687.85FALSE2.50
2028-01-21120CALL0 1098.17FALSE00
2028-01-21150CALL0 073.84FALSE00
2028-01-21170CALL0 0108.19FALSE00
2028-01-21200CALL0 4120.59FALSE00
2028-01-21220CALL0 1183.45FALSE00
2028-01-2130PUT0 2155.36FALSE00
2028-01-2150PUT0 4664.23FALSE00
2028-01-2180PUT0 273.85TRUE00
2028-01-21100PUT0 075.08TRUE00
2028-01-21120PUT0 072.64TRUE00
2028-01-21150PUT0 5078.54TRUE00
2028-01-21170PUT0 077.72TRUE00
2028-01-21200PUT0 077.65TRUE00
2028-01-21220PUT0 070.67TRUE00

Latest WVE Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST17$1.995
Jun 13, 2022 7:59 PM EST100$2
Jun 13, 2022 7:59 PM EST17$1.995
Jun 13, 2022 7:59 PM EST17$1.995
Jun 13, 2022 7:59 PM EST100$1.995

Wave Life Sciences Ltd (WVE) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2019-08-09UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1631574/000000000019012261/0000000000-19-012261-index.htm
2019-11-27UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1631574/000000000019015921/0000000000-19-015921-index.htm
2019-12-06UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1631574/000000000019016177/0000000000-19-016177-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000008025519002715/0000080255-19-002715-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000008025520001311/0000080255-20-001311-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000021545719006909/0000215457-19-006909-index.htm
2019-03-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000021545719007594/0000215457-19-007594-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000083423720008192/0000834237-20-008192-index.htm
2020-08-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000089542120000470/0000895421-20-000470-index.htm
2018-08-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924318022514/0000899243-18-022514-index.htm
2018-08-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924318022515/0000899243-18-022515-index.htm
2018-09-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924318025318/0000899243-18-025318-index.htm
2018-09-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924318025320/0000899243-18-025320-index.htm
2018-09-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924318025322/0000899243-18-025322-index.htm
2018-11-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924318029157/0000899243-18-029157-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319004460/0000899243-19-004460-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319004462/0000899243-19-004462-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319004464/0000899243-19-004464-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319004466/0000899243-19-004466-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319004467/0000899243-19-004467-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319007106/0000899243-19-007106-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319007110/0000899243-19-007110-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319007112/0000899243-19-007112-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319007113/0000899243-19-007113-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319007114/0000899243-19-007114-index.htm
2019-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319008404/0000899243-19-008404-index.htm
2019-07-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319019395/0000899243-19-019395-index.htm
2019-08-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021292/0000899243-19-021292-index.htm
2019-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021293/0000899243-19-021293-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021959/0000899243-19-021959-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021962/0000899243-19-021962-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021963/0000899243-19-021963-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021965/0000899243-19-021965-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021966/0000899243-19-021966-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021967/0000899243-19-021967-index.htm
2019-09-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319023028/0000899243-19-023028-index.htm
2019-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319023032/0000899243-19-023032-index.htm
2019-09-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319023033/0000899243-19-023033-index.htm
2019-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319023034/0000899243-19-023034-index.htm
2019-09-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319023035/0000899243-19-023035-index.htm
2019-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319023038/0000899243-19-023038-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319027985/0000899243-19-027985-index.htm
2019-12-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319028606/0000899243-19-028606-index.htm
2020-01-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320001393/0000899243-20-001393-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320003379/0000899243-20-003379-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320005342/0000899243-20-005342-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320005346/0000899243-20-005346-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320005349/0000899243-20-005349-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320005351/0000899243-20-005351-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320007277/0000899243-20-007277-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320007281/0000899243-20-007281-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320007282/0000899243-20-007282-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320007284/0000899243-20-007284-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320007285/0000899243-20-007285-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023078/0000899243-20-023078-index.htm
2020-08-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023079/0000899243-20-023079-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023080/0000899243-20-023080-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023085/0000899243-20-023085-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023086/0000899243-20-023086-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023087/0000899243-20-023087-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023088/0000899243-20-023088-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023089/0000899243-20-023089-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023092/0000899243-20-023092-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023093/0000899243-20-023093-index.htm
2020-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023540/0000899243-20-023540-index.htm
2020-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320025614/0000899243-20-025614-index.htm
2020-01-28SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000090221920000204/0000902219-20-000204-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000110465920021834/0001104659-20-021834-index.htm
2019-01-28SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1631574/000114420419003157/0001144204-19-003157-index.htm
2019-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000114420419003160/0001144204-19-003160-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000114420419008078/0001144204-19-008078-index.htm
2018-09-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312518270464/0001193125-18-270464-index.htm
2018-10-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312518290300/0001193125-18-290300-index.htm
2018-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312518291962/0001193125-18-291962-index.htm
2018-10-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312518295345/0001193125-18-295345-index.htm
2018-11-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312518323137/0001193125-18-323137-index.htm
2018-11-09S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1631574/000119312518323760/0001193125-18-323760-index.htm
2018-12-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312518342992/0001193125-18-342992-index.htm
2019-01-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519001144/0001193125-19-001144-index.htm
2019-01-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1631574/000119312519014851/0001193125-19-014851-index.htm
2019-01-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519014884/0001193125-19-014884-index.htm
2019-01-24424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1631574/000119312519015961/0001193125-19-015961-index.htm
2019-01-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519015976/0001193125-19-015976-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000119312519040844/0001193125-19-040844-index.htm
2019-02-20SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1631574/000119312519045277/0001193125-19-045277-index.htm
2019-03-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519059251/0001193125-19-059251-index.htm
2019-03-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1631574/000119312519074933/0001193125-19-074933-index.htm
2019-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519107259/0001193125-19-107259-index.htm
2019-04-2910-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1631574/000119312519125660/0001193125-19-125660-index.htm
2019-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519143674/0001193125-19-143674-index.htm
2019-05-10S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1631574/000119312519144278/0001193125-19-144278-index.htm
2019-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519165571/0001193125-19-165571-index.htm
2019-06-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1631574/000119312519182697/0001193125-19-182697-index.htm
2019-07-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519205421/0001193125-19-205421-index.htm
2019-08-06S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1631574/000119312519214152/0001193125-19-214152-index.htm
2019-08-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1631574/000119312519214169/0001193125-19-214169-index.htm
2019-08-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1631574/000119312519218981/0001193125-19-218981-index.htm
2019-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519221246/0001193125-19-221246-index.htm
2019-08-168-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519223468/0001193125-19-223468-index.htm
2019-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519238229/0001193125-19-238229-index.htm
2019-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519263797/0001193125-19-263797-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519284729/0001193125-19-284729-index.htm
2019-11-05S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1631574/000119312519284817/0001193125-19-284817-index.htm
2019-12-03CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1631574/000119312519304738/0001193125-19-304738-index.htm
2019-12-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519314469/0001193125-19-314469-index.htm
2019-12-23SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000119312519322733/0001193125-19-322733-index.htm
2019-12-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519325442/0001193125-19-325442-index.htm
2020-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520005483/0001193125-20-005483-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520005882/0001193125-20-005882-index.htm
2020-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520026760/0001193125-20-026760-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000119312520037841/0001193125-20-037841-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000119312520038291/0001193125-20-038291-index.htm
2020-03-02POSASRPost-effective Amendment to an automatic shelf registration statementhttps://www.sec.gov/Archives/edgar/data/1631574/000119312520057766/0001193125-20-057766-index.htm
2020-03-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520057791/0001193125-20-057791-index.htm
2020-03-02POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1631574/000119312520057905/0001193125-20-057905-index.htm
2020-04-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520107212/0001193125-20-107212-index.htm
2020-04-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520117339/0001193125-20-117339-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520138276/0001193125-20-138276-index.htm
2020-06-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1631574/000119312520181069/0001193125-20-181069-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520214106/0001193125-20-214106-index.htm
2020-08-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1631574/000119312520214144/0001193125-20-214144-index.htm
2020-08-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1631574/000119312520214223/0001193125-20-214223-index.htm
2020-08-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520223731/0001193125-20-223731-index.htm
2020-08-198-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520224764/0001193125-20-224764-index.htm
2020-08-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520229903/0001193125-20-229903-index.htm
2020-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520241608/0001193125-20-241608-index.htm
2020-09-22424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1631574/000119312520251261/0001193125-20-251261-index.htm
2020-09-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520251297/0001193125-20-251297-index.htm
2020-09-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1631574/000119312520252307/0001193125-20-252307-index.htm
2020-09-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520252347/0001193125-20-252347-index.htm
2020-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520254552/0001193125-20-254552-index.htm
2020-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520260543/0001193125-20-260543-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000127417319000113/0001274173-19-000113-index.htm
2019-08-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000127417319000120/0001274173-19-000120-index.htm
2020-01-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000127417320000004/0001274173-20-000004-index.htm
2020-01-21SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000149315220000835/0001493152-20-000835-index.htm
2018-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631574/000156459018028757/0001564590-18-028757-index.htm
2019-03-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1631574/000156459019005671/0001564590-19-005671-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631574/000156459019018521/0001564590-19-018521-index.htm
2019-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631574/000156459019029396/0001564590-19-029396-index.htm
2019-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631574/000156459019040431/0001564590-19-040431-index.htm
2020-03-0210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1631574/000156459020007972/0001564590-20-007972-index.htm
2020-04-2910-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1631574/000156459020019772/0001564590-20-019772-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631574/000156459020023860/0001564590-20-023860-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631574/000156459020038620/0001564590-20-038620-index.htm
2019-08-14EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1631574/999999999519001883/9999999995-19-001883-index.htm
2020-05-01EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1631574/999999999520000974/9999999995-20-000974-index.htm
2018-09-17CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1631574/999999999718007937/9999999997-18-007937-index.htm

Wave Life Sciences Ltd (WVE) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Wave Life Sciences Ltd (WVE). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1297%
Institutional Ownership: 7671%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-02-19Keith RegnanteChief Financial OfficerSell1,298.0036.8447,817.8015,686.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319004467/0000899243-19-004467-index.htm
2018-09-24Keith RegnanteChief Financial OfficerSell29,500.0055.001,622,500.0016,984.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025320/0000899243-18-025320-index.htm
2019-02-19Chris FrancisOfficerSell1,709.0036.8462,959.0520,368.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319004460/0000899243-19-004460-index.htm
2018-09-24Chris FrancisOfficerSell1,032.0056.0057,792.0022,077.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025322/0000899243-18-025322-index.htm
2018-09-25Chris FrancisOfficerSell10,543.0056.00590,408.0022,077.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025322/0000899243-18-025322-index.htm
2018-09-24Chris FrancisOfficerBuy1,032.002.482,559.3623,109.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025322/0000899243-18-025322-index.htm
2019-02-19Chandra VargeeseSenior VP, Drug DiscoverySell2,055.0036.8475,706.2025,245.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319004462/0000899243-19-004462-index.htm
2019-02-19PAUL BOLNOPresident and CEOSell119.0037.474,458.45271,209.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319004464/0000899243-19-004464-index.htm
2019-02-19PAUL BOLNOPresident and CEOSell7,614.0036.38276,997.32271,328.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319004464/0000899243-19-004464-index.htm
2020-07-02PAUL BOLNOPresident and CEOSell43,068.0010.26441,877.68272,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2020-07-02PAUL BOLNOPresident and CEOSell95,921.0010.27985,108.67272,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2020-08-25PAUL BOLNOPresident and CEOSell25,000.0012.00300,000.00272,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320023540/0000899243-20-023540-index.htm
2020-09-15PAUL BOLNOPresident and CEOSell100,000.0015.001,500,000.00272,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320025614/0000899243-20-025614-index.htm
2018-09-24Chandra VargeeseSenior VP, Drug DiscoverySell3,000.0055.00165,000.0027,300.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025318/0000899243-18-025318-index.htm
2019-03-07Keith RegnanteChief Financial OfficerBuy13,500.0029,186.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319007114/0000899243-19-007114-index.htm
2020-08-25PAUL BOLNOPresident and CEOBuy25,000.002.4862,000.00297,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320023540/0000899243-20-023540-index.htm
2019-11-20Gregory L. VerdineDirectorSell2,609.0032.7485,418.6630,000.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319027985/0000899243-19-027985-index.htm
2018-09-24Chandra VargeeseSenior VP, Drug DiscoveryBuy3,000.002.487,440.0030,300.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025318/0000899243-18-025318-index.htm
2020-02-18Chris FrancisOfficerSell2,708.007.8521,257.8031,160.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320005346/0000899243-20-005346-index.htm
2020-07-02PAUL BOLNOPresident and CEOSell4,509.0010.8248,787.38315,249.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2020-02-18PAUL BOLNOPresident and CEOSell11,451.007.8589,890.35319,758.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320005349/0000899243-20-005349-index.htm
2019-11-20Gregory L. VerdineDirectorSell3,400.0031.59107,406.0032,609.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319027985/0000899243-19-027985-index.htm
2018-09-25Chris FrancisOfficerBuy10,543.002.4826,146.6432,620.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025322/0000899243-18-025322-index.htm
2019-03-07PAUL BOLNOPresident and CEOBuy60,000.00331,209.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319007112/0000899243-19-007112-index.htm
2019-03-15PAUL BOLNOPresident and CEOSell1,763.0046.0081,098.00331,209.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319008404/0000899243-19-008404-index.htm
2019-03-15PAUL BOLNOPresident and CEOSell8,237.0045.22372,477.14332,972.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319008404/0000899243-19-008404-index.htm
2019-03-07Chris FrancisOfficerBuy13,500.0033,868.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319007110/0000899243-19-007110-index.htm
2019-03-15PAUL BOLNOPresident and CEOSell5,065.0045.89232,432.85341,209.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319008404/0000899243-19-008404-index.htm
2019-03-15PAUL BOLNOPresident and CEOSell34,935.0045.451,587,795.75346,274.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319008404/0000899243-19-008404-index.htm
2019-08-05Mark BaldryChief Commerical OfficerBuy35,000.0035,000.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319021293/0000899243-19-021293-index.htm
2019-11-20Gregory L. VerdineDirectorSell24,030.0030.27727,388.1036,009.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319027985/0000899243-19-027985-index.htm
2020-07-02PAUL BOLNOPresident and CEOSell4,079.0010.9144,501.89368,102.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2020-02-18Chandra VargeeseSenior VP, Drug DiscoverySell3,188.007.8525,025.8037,057.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320005342/0000899243-20-005342-index.htm
2020-07-02PAUL BOLNOPresident and CEOBuy100,000.002.48248,000.00372,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2020-09-15PAUL BOLNOPresident and CEOBuy100,000.002.48248,000.00372,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320025614/0000899243-20-025614-index.htm
2019-02-19Michael A. PanzaraFranchise Lead, NeurologySell1,837.0036.8467,673.9837,388.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319004466/0000899243-19-004466-index.htm
2019-03-15PAUL BOLNOPresident and CEOBuy50,000.002.48124,000.00381,209.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319008404/0000899243-19-008404-index.htm
2019-08-05Mark BaldryChief Commerical OfficerBuy4,000.0039,000.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319021293/0000899243-19-021293-index.htm
2020-02-18Michael A. PanzaraChief Medical OfficerSell2,981.007.8523,400.8539,349.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320005351/0000899243-20-005351-index.htm
2019-03-07Chandra VargeeseSenior VP, Drug DiscoveryBuy15,000.0040,245.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319007106/0000899243-19-007106-index.htm
2019-12-03Chandra VargeeseSenior VP, Drug DiscoverySell6,000.0035.00210,000.0040,245.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319028606/0000899243-19-028606-index.htm
2019-07-05Michael A. PanzaraChief Medical OfficerSell445.0027.2612,130.7042,330.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319019395/0000899243-19-019395-index.htm
2019-07-05Michael A. PanzaraChief Medical OfficerSell2,613.0026.8870,237.4442,775.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319019395/0000899243-19-019395-index.htm
2019-03-11Michael A. PanzaraFranchise Lead, NeurologySell7,000.0048.00336,000.0045,388.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319007113/0000899243-19-007113-index.htm
2019-12-03Chandra VargeeseSenior VP, Drug DiscoveryBuy6,000.002.4814,880.0046,245.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319028606/0000899243-19-028606-index.htm
2018-09-24Keith RegnanteChief Financial OfficerBuy29,500.0020.89616,255.0046,484.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025320/0000899243-18-025320-index.htm
2019-03-07Michael A. PanzaraFranchise Lead, NeurologyBuy15,000.0052,388.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319007113/0000899243-19-007113-index.htm
2018-11-14Gregory L. VerdineDirectorSell4,300.0039.52169,936.0060,039.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318029157/0000899243-18-029157-index.htm
2020-02-03David G GaieroInterim CFOSell651.007.004,557.006,392.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320003379/0000899243-20-003379-index.htm
2018-11-14Gregory L. VerdineDirectorSell10,700.0038.59412,913.0064,339.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318029157/0000899243-18-029157-index.htm
2019-01-24RA CAPITAL MANAGEMENT, LLCDirectorBuy263,158.0038.0010,000,004.007,775,207.00https://www.sec.gov/Archives/edgar/data/1631574/000114420419003160/0001144204-19-003160-index.htm